<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
  <channel>
    <title>PuSH - HMGU Publikationen</title>
    <link>https://push-zb.helmholtz-munich.de</link>
    <description>
    PuSH - Publikationen-Server des Helmholtz Zentrums München
    </description>
    <language>de-de</language>

    <item>
      <title><![CDATA[Sahu, T.* ; Jagzape, A.T.* ; Sinha, M.* ; Sinha, R.* &amp; Verma, H.K. New frontiers in sickle cell disease: The role of antiviral therapies and emerging drugs in managing viral infections. World J. Virol. 14:101693 (2025)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=75033&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=75033&amp;la=de</guid>
      <pubDate>Tue, 01 Jul 2025 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Mohanty, P.* et al. Emerging perspectives on RNA virus-mediated infections: From pathogenesis to therapeutic interventions. World J. Virol. 12, 242-255 (2023)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=69768&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=69768&amp;la=de</guid>
      <pubDate>Tue, 16 Jan 2024 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Sahu, T.* ; Verma, H.K. &amp; Bhaskar, L.V.K.S.* Bacterial and fungal co-infection is a major barrier in COVID-19 patients: A specific management and therapeutic strategy is required. World J. Virol. 11, 107-110 (2022)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64784&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=64784&amp;la=de</guid>
      <pubDate>Fri, 29 Jul 2022 00:00:00 +0000</pubDate>
    </item>
    
    <item>
      <title><![CDATA[Sahu, T.* ; Verma, H.K. &amp; Lvks, B.* Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategy. World J. Virol. 11, 204-207 (2022)]]></title>
      <description><![CDATA[]]></description>
      <link>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66383&amp;la=de</link>
      <guid>https://push-zb.helmholtz-munich.de/frontdoor.php?source_opus=66383&amp;la=de</guid>
      <pubDate>Thu, 24 Nov 2022 00:00:00 +0000</pubDate>
    </item>
    </channel>
</rss>